Role of the oral and maxillofacial surgeon in the diagnosis and treatment of patients with osteoporosis.
Role of the oral and maxillofacial surgeon in the diagnosis and treatment of patients with osteoporosis.
复制标题
DOI：
10.1016/j.coms.2007.06.003
复制
发表时间：
2007-11-01
影响因子：
1.5
通讯作者：
Isales, Carlos M
中科院分区：
文献类型：
--
作者：
Isales, Carlos M
由于骨质疏松症在老年人群中的患病率越来越高，因此口腔外科医生了解这种情况是很重要的。口腔健康经常反映全身性疾病，牙齿中的钙流失可能反映骨骼中的全身性矿物质流失。慢性健康状况，如骨质疏松症，也可能影响手术结果。在过去，骨质疏松症的治疗仅限于激素替代疗法和氟化物。最近，骨质疏松症的新疗法层出不穷，可能会影响牙齿健康。使用双膦酸盐与颌骨骨坏死之间的关系值得关注。重要的是，口腔外科医生在开始任何手术之前都要了解患者正在使用的治疗骨质疏松症的药物。
Because of the increasing prevalence of osteoporosis in the aging population, it is important for oral surgeons to be aware of this condition. Oral health frequently reflects systemic diseases, and calcium loss in the teeth may mirror systemic mineral losses in the skeleton. Chronic health conditions, such as osteoporosis, also may affect surgical outcomes. In the past, therapies of osteoporosis were limited to hormonal replacement therapy and fluoride. Recently, there has been a proliferation of new therapies for osteoporosis that may affect dental health. The association between bisphosphonate use and osteonecrosis of the jaw is of concern. It is important that oral surgeons be aware of the medications a patient is using for the treatment of osteoporosis before initiating any procedure.